MNOV vs ACIU โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MNOV Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Medicinova, Inc. (MNOV) driven by superior Momentum & Technical, Options & Structure while ACIU counters with relative strength in Valuation, Growth & Margin. Fundamentally, MNOV trades at 8.5x Forward P/E with -1232.2% operating margin (+12.4% YoY revenue) versus ACIU at 3.4x Forward P/E and -190.8% operating margin (+245.5% YoY). In options structure, MNOV sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against ACIU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MNOV | ACIU | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $65.1M | $211.8M | Larger Scale | ACIU |
| Trailing P/E Ratio Valuation | 8.5x | 4.9x | Lower Multiple | ACIU |
| Forward P/E Ratio Valuation | 8.5x | 3.4x | Lower Multiple | ACIU |
| Revenue Growth (YoY) Growth | +12.4% | +245.5% | Higher Growth | ACIU |
| Operating Margin (TTM) Profitability | -1232.2% | -190.8% | Higher Margin | ACIU |
| Net Profit Margin Profitability | 0.0% | -181.9% | Higher Margin | MNOV |
| Return on Equity (ROE) Capital Efficiency | -24.8% | -80.7% | Higher ROE | MNOV |
| 52-Week Range Position Momentum | 3% ($1โ$4) | 1% ($2โ$4) | Stronger Trend | MNOV |
| Beta / 30D Volatility Risk Regime | 0.59ฮฒ ยท 38% Vol | 1.42ฮฒ ยท 80% Vol | Lower Realized Risk | MNOV |
| Unified Institutional Score Composite Signal | 50.2 / 100 (HOLD) | 47.3 / 100 (HOLD) | Higher Composite | MNOV |